Hello, everyone, and welcome to the 2026 Annual Meeting of Stockholders for Aclaris Therapeutics, Inc. My name is Morgan, and I will be your operator today. Please note that today's meeting is being recorded. I would now like to introduce Dr. Neal Walker, Chief Executive Officer of Aclaris Therapeutics, Inc. Good morning. I am Neal Walker, and I'm the Chief Executive Officer and Chair of the Board of Directors of Aclaris Therapeutics. I'm very happy to welcome you to the Aclaris Therapeutics 2026 Annual Stockholders' Meeting. We are holding the annual meeting virtually to facilitate stockholder participation in the annual meeting. Before I call the meeting to order, I'd like to introduce to you two members of the Board and the business team who are with us today. The other members of the Board with us today are Vin Milano and Chris Molineaux. The other officers with us today are Hugh Davis, our President and Chief Operating Officer, Kevin Balthaser, our Chief Financial Officer, Roland Kolbeck, our Chief Scientific Officer, Jesse Hall, our Chief Medical Officer, and Jim Lara, our Chief Business Officer. Matthew Rothman, our General Counsel and Corporate Secretary, is also with us today. I would also like to introduce Bill Liva and Greg Pellicano of PricewaterhouseCoopers, our independent registered public accounting firm who are available to respond to appropriate questions. Mark Ballantyne and David Brinton of Cooley, our outside Corporate Counsel, are also with us today. Lastly, I would like to introduce Jan Castillo, who will act as our Inspector of Election at the meeting. The meeting will now officially come to order. We will proceed with the formal business of the meeting as set forth in your Notice of Annual Meeting and Proxy Statement. After the formal part of our meeting, we will respond to any appropriate questions from stockholders. The agenda and rules of conduct for the meeting have been provided on the meeting website. As stated in the rules of conduct, only validated stockholders may ask text questions in the designated field on the meeting website. To allow us to answer questions from as many stockholders as possible, stockholders will only be permitted to ask one question, and only questions germane to our business or the meeting will be answered as time permits. Will the Secretary please report at this time with respect to the proof of mailing? I have at this meeting an affidavit certifying that on April 23rd, 2026, either a notice of Internet availability of proxy materials or a written notice of Annual Meeting of Stockholders, a Proxy Statement, a proxy card, and our 2025 Annual Report was deposited in the U.S. Mail to all stockholders of record at the close of business on April 14th, 2026. At this time, I'd like to appoint Jan Castillo to act as the Inspector of Election at this meeting. Jan Castillo has taken and subscribed the customary oath of office to execute her duties with strict impartiality. We will file this oath with the records of the meeting. Her function is to decide upon the qualifications of voters, accept their votes, and when voting on all matters is completed, to tally the final votes. Will the Secretary please report at this time with respect to the existence of a quorum? I've been informed by the Inspector of Election that proxies have been received for 112,499,671 of the 139,663,680 shares of common stock outstanding on the record date, which represents 80.55% of the total number of outstanding shares. This constitutes a quorum for the meeting today, and we may now carry out the official business of the meeting. We will now proceed with the formal business of this meeting. There are three proposals to be considered by the stockholders at this meeting. The time is now 9:04 A.M. on Thursday, June 4th, and the polls are now open for voting on all matters to be presented. If you have not yet already voted your shares or wish to change your vote, you may vote by clicking on the voting button on the web portal prior to the closing of the polls. The polls will be closed to voting after we go through the matters to be voted on. The first item of business is the election of two Class II Directors to serve until the 2029 Annual Meeting of Stockholders and until their successors are elected and qualified. The nominees for Class II Director are Anand Mehra and Maxine Gowen. If any stockholder would like to make a comment regarding this proposal, please submit your comment through the web portal. The second item of business is the advisory vote on the compensation of the company's named executive officers as described in the Proxy Statement. The stockholders have been asked to vote on an advisory basis on the following resolution. Resolved, that the compensation paid to the company's named executive officers as disclosed pursuant to Item 402 of Regulation S-K, including the compensation tables and narrative discussion, is hereby approved. If any stockholder would like to make a comment regarding this proposal, please submit your comment through the web portal. The third item of business today is the ratification of the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers as our independent registered public accounting firm for the fiscal year ending December 31st, 2026. If any stockholder would like to make a comment regarding this proposal, please submit your comment through the web portal. That was the final proposal for today's meeting. The Secretary will now describe the voting procedures. You may vote your shares at this time. You do not need to vote if you have already sent in your signed proxy or voted via telephone or online before the meeting, and you do not want to change your vote. Any stockholder who has not yet voted or wishes to change their vote may do so by clicking on the voting button on the web portal and following the instructions there. Each share of common stock is entitled to one vote. The time is now 9:08 A.M., and the polls are now closed for voting. May we have the results of the voting? The preliminary vote report of the Inspector of Election covering the proposals presented at the meeting is as follows. The proposal to elect Anand Mehra and Maxine Gowen as our Class II Directors is carried. The resolution concerning the advisory vote on the compensation of the company's named executive officers is approved. The selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026, is ratified. We expect to report our voting results on a current report on Form 8-K to be filed with the SEC within four business days after the end of this meeting. This concludes the formal portion of today's meeting. Now we would like to open things up for stockholder questions and comments. We will take stockholder questions that are submitted today through the web portal. Please note we will attempt to answer as many questions as time allows, but only questions that are germane to the meeting will be addressed. As there are no questions, is there any opposition to concluding this meeting? Operator, this meeting is adjourned. Thank you. Ladies and gentlemen, this concludes the 2026 Annual Meeting of Stockholders. Thank you for attending today's meeting. Enjoy the rest of your day.